Stock Taper
SCREENER COMPARE ANY 2 STOCKS
LLY
ELI LILLY AND COMPANY
NYSE
$1172.86
▼ DOWN 0.28% (-3.24)

KEY STATISTICS

Market Cap$1.10 T
52w High$1292.65
52w Low$712.05
Dividend Yield0.59%
FrequencyQuarterly
P/E37.25
Volume2.45M
Shares Out.941.74M

COMPANY

LEADERSHIP

David A. Ricks
CHIEF EXECUTIVE
David A. Ricks

COMPENSATION 2026

Salary$1,700,000
Stock Awards$23,325,000
Incentive Plan Pay$6,485,500
All Other Comp.$736,201
Total$36,698,337

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 1, 1972
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
50,000

PRICE TARGET

Target High$1500.00
Target Low$1135.00
Target Median$1360.00
Target Consensus$1341.63

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$22.14B
OCT
29
THU

SPLIT RECORD

DATETYPERATIO
1997-10-16Forward2:1
1995-12-21Forward2:1
1989-05-01Forward2:1
1986-01-30Forward2:1

PRICE

$1172.86 ▼ DOWN 0.28% (−$3.24)
OVERLAYS
$1165$1170$11759:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM1172.86

About Eli Lilly and Company

https://www.lilly.com ↗

Eli Lilly and Company, founded in 1876 and based in Indianapolis, develops and markets global pharmaceuticals including insulin, cancer treatments, and therapies for diabetes, rheumatoid arthritis, depression, and COVID-19, through numerous collab...

INDUSTRY

Drug Manufacturers - General

A PRODUCT ELI LILLY AND COMPANY IS KNOWN FOR

Zepbound
Zepbound

Zepbound, an FDA-approved injectable prescription for chronic weight management in adults with obesity or overweight with related conditions, contains tirzepatide, a dual GIP and GLP-1 receptor agonist, and is a key growth driver for Eli Lilly in ...

COMPETITORS

COMPETITOR
AMGN COMPARE
MRK COMPARE
NVO COMPARE
PFE COMPARE
VKTX COMPARE

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q1-2026Q2-2026
Cardiometabolic Health$11.34B $13.18B ▲$15.76B ▲$18.35B ▲
Oncology$2.41B $2.41B ▼$2.27B ▼$2.57B ▲
Immunology$1.26B $1.36B ▲$1.2B ▼$1.42B ▲
Neuroscience$344M $315.7M ▼$382M ▲$429M ▲
Other Product Total$201.5M $337.2M ▲— —

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$11.3B $12.88B ▲$12.12B ▼$14.41B ▲
Europe$3.5B $3.1B ▼$3.65B ▲$4.12B ▲
NonUS$1.69B $2.19B ▲$10.45B ▲$2.88B ▼
CHINA$560.4M $473.9M ▼$693M ▲$941M ▲
JAPAN$554.7M $654.1M ▲$571M ▼$628M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
1,396
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
1.35% · 27.6M
IVV.AX
1.47% · 10.6M
SPY
1.40% · 9.7M
SCHG
2.96% · 1.6M
SMTC.L
3.29% · 699.2K
CGDV
1.92% · 638.9K
DUHP
4.49% · 488.9K
JEPI
0.98% · 387.5K
FHLC
12.91% · 385.4K
XDWH.L
10.97% · 379.3K
AVLV
2.04% · 374.2K
HMWA.L
2.14% · 333.4K
XZ
XZME.F
3.34% · 275.1K
ZSP.TO
1.40% · 246.4K
DGRW
1.46% · 211.4K
XLG
2.24% · 210.9K
QUAL.AX
3.48% · 185.5K
GSLC
1.23% · 160.3K
WRDUSW.SW
1.05% · 151.8K
SPYI
1.45% · 144.6K
NULG
4.13% · 108.7K
QLTY
2.70% · 105.2K
USMC
2.41% · 103.9K
BKLC
1.48% · 72.8K
SSO
0.96% · 72.6K
ARKG
3.72% · 67.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
57.13%
HOLDERS
5,438
TOP 12 OF 5,438 · RANKED BY POSITION SIZE
Lilly Endowment Inc
95.5M sh · $72.86B
Vanguard Group Inc
82.0M sh · $88.09B
Blackrock, Inc.
67.5M sh · $81.01B
Blackrock Inc.
65.9M sh · $59.62B
Pnc Financial Services Group, Inc.
51.4M sh · $39.19B
State Street Corp
36.2M sh · $43.44B
Fmr LLC
28.5M sh · $34.14B
Blackrock Institutional Trust Company, N.A.
26.6M sh · $1.96B
Capital Research Global Investors
25.1M sh · $19.14B
Geode Capital Management, LLC
20.3M sh · $24.28B
State Farm Investment Management Corp
20.1M sh · $809.91K
Blackrock Fund Advisors
19.1M sh · $1.4B

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Purchase
2026-04-14
 Elizabeth Fletcher
Elizabeth Fletcher
Sale
2026-04-08
 Lizzie Fletcher
Lizzie Fletcher
Sale
2026-04-08
 Byron Donalds
Byron Donalds
Purchase
2026-04-02

INSIDER TRADES

★
OFFICER: EVP & PRESIDENT, LLY INT'L
Jonsson Patrik
Sale · 6.5K shares
2026-08-17
★
DIRECTOR
Sulzberger Gabrielle
Purchase · 4 shares
2026-08-17
★
DIRECTOR
Fyrwald J Erik
Purchase · 8 shares
2026-08-17
★
DIRECTOR
Alvarez Ralph
Purchase · 10 shares
2026-08-17

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 8
OVERWEIGHT 5
OUTPERFORM 5
HOLD 2
REDUCE 1
21 GRADES IN THE LAST 12 MONTHS
Truist Securities BUY Cantor Fitzgerald OVERWEIGHT Wells Fargo OVERWEIGHT Citigroup BUY Bernstein OUTPERFORM Guggenheim BUY UBS BUY B of A Securities BUY

SECTORS PEERS

PEERPRICE
JNJ$268.04COMPARE
ABBV$255.48COMPARE
MRK$148.26COMPARE
NVS$153.81COMPARE
AZN$162.70COMPARE
AMGN$432.42COMPARE
NVO$45.61COMPARE
GILD$145.68COMPARE